ADX 106772
Alternative Names: ADX-106772Latest Information Update: 28 Jul 2023
At a glance
- Originator Addex Therapeutics
- Class Drug withdrawal therapies; Small molecules
- Mechanism of Action Metabotropic glutamate receptor 2 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Opioid-related disorders